Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans

Sanne P. Smeekens, Aylwin Ng, Vinod Kumar, Melissa D. Johnson, Theo S. Plantinga, Cleo Van Diemen, Peer Arts, Eugène T P Verwiel, Mark S. Gresnigt, Karin Fransen, Suzanne Van Sommeren, Marije Oosting, Shih Chin Cheng, Leo A B Joosten, Alexander Hoischen, Bart Jan Kullberg, William K Scott, John R. Perfect, Jos W M Van Der Meer, Cisca WijmengaMihai G. Netea, Ramnik J. Xavier

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Candida albicans is the most common human fungal pathogen causing mucosal and systemic infections. However, human antifungal immunity remains poorly defined. Here by integrating transcriptional analysis and functional genomics, we identified Candida-specific host defence mechanisms in humans. Candida induced significant expression of genes from the type I interferon pathway in human peripheral blood mononuclear cells. This unexpectedly prominent role of type I interferon pathway in anti-Candida host defence was supported by additional evidence. Polymorphisms in type I interferon genes modulated Candida-induced cytokine production and were correlated with susceptibility to systemic candidiasis. In in vitro experiments, type I interferons skewed Candida-induced inflammation from a Th17 response towards a Th1 response. Patients with chronic mucocutaneous candidiasis displayed defective expression of genes in the type I interferon pathway. These findings indicate that the type I interferon pathway is a main signature of Candida-induced inflammation and has a crucial role in anti-Candida host defence in humans.

Original languageEnglish
Article number1342
JournalNature Communications
Volume4
DOIs
StatePublished - Oct 28 2013

Fingerprint

interferon
Candida
Interferon Type I
Genomics
Candida albicans
Interferons
genes
Genes
Chronic Mucocutaneous Candidiasis
blood cells
pathogens
Inflammation
Gene Expression
polymorphism
immunity
infectious diseases
Pathogens
Polymorphism
signatures
Immunity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Smeekens, S. P., Ng, A., Kumar, V., Johnson, M. D., Plantinga, T. S., Van Diemen, C., ... Xavier, R. J. (2013). Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans. Nature Communications, 4, [1342]. https://doi.org/10.1038/ncomms2343

Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans. / Smeekens, Sanne P.; Ng, Aylwin; Kumar, Vinod; Johnson, Melissa D.; Plantinga, Theo S.; Van Diemen, Cleo; Arts, Peer; Verwiel, Eugène T P; Gresnigt, Mark S.; Fransen, Karin; Van Sommeren, Suzanne; Oosting, Marije; Cheng, Shih Chin; Joosten, Leo A B; Hoischen, Alexander; Kullberg, Bart Jan; Scott, William K; Perfect, John R.; Van Der Meer, Jos W M; Wijmenga, Cisca; Netea, Mihai G.; Xavier, Ramnik J.

In: Nature Communications, Vol. 4, 1342, 28.10.2013.

Research output: Contribution to journalArticle

Smeekens, SP, Ng, A, Kumar, V, Johnson, MD, Plantinga, TS, Van Diemen, C, Arts, P, Verwiel, ETP, Gresnigt, MS, Fransen, K, Van Sommeren, S, Oosting, M, Cheng, SC, Joosten, LAB, Hoischen, A, Kullberg, BJ, Scott, WK, Perfect, JR, Van Der Meer, JWM, Wijmenga, C, Netea, MG & Xavier, RJ 2013, 'Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans', Nature Communications, vol. 4, 1342. https://doi.org/10.1038/ncomms2343
Smeekens, Sanne P. ; Ng, Aylwin ; Kumar, Vinod ; Johnson, Melissa D. ; Plantinga, Theo S. ; Van Diemen, Cleo ; Arts, Peer ; Verwiel, Eugène T P ; Gresnigt, Mark S. ; Fransen, Karin ; Van Sommeren, Suzanne ; Oosting, Marije ; Cheng, Shih Chin ; Joosten, Leo A B ; Hoischen, Alexander ; Kullberg, Bart Jan ; Scott, William K ; Perfect, John R. ; Van Der Meer, Jos W M ; Wijmenga, Cisca ; Netea, Mihai G. ; Xavier, Ramnik J. / Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans. In: Nature Communications. 2013 ; Vol. 4.
@article{0fb1afa1c1fa4a67898ba1d0b7f5231b,
title = "Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans",
abstract = "Candida albicans is the most common human fungal pathogen causing mucosal and systemic infections. However, human antifungal immunity remains poorly defined. Here by integrating transcriptional analysis and functional genomics, we identified Candida-specific host defence mechanisms in humans. Candida induced significant expression of genes from the type I interferon pathway in human peripheral blood mononuclear cells. This unexpectedly prominent role of type I interferon pathway in anti-Candida host defence was supported by additional evidence. Polymorphisms in type I interferon genes modulated Candida-induced cytokine production and were correlated with susceptibility to systemic candidiasis. In in vitro experiments, type I interferons skewed Candida-induced inflammation from a Th17 response towards a Th1 response. Patients with chronic mucocutaneous candidiasis displayed defective expression of genes in the type I interferon pathway. These findings indicate that the type I interferon pathway is a main signature of Candida-induced inflammation and has a crucial role in anti-Candida host defence in humans.",
author = "Smeekens, {Sanne P.} and Aylwin Ng and Vinod Kumar and Johnson, {Melissa D.} and Plantinga, {Theo S.} and {Van Diemen}, Cleo and Peer Arts and Verwiel, {Eug{\`e}ne T P} and Gresnigt, {Mark S.} and Karin Fransen and {Van Sommeren}, Suzanne and Marije Oosting and Cheng, {Shih Chin} and Joosten, {Leo A B} and Alexander Hoischen and Kullberg, {Bart Jan} and Scott, {William K} and Perfect, {John R.} and {Van Der Meer}, {Jos W M} and Cisca Wijmenga and Netea, {Mihai G.} and Xavier, {Ramnik J.}",
year = "2013",
month = "10",
day = "28",
doi = "10.1038/ncomms2343",
language = "English",
volume = "4",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Functional genomics identifies type i interferon pathway as central for host defense against Candida albicans

AU - Smeekens, Sanne P.

AU - Ng, Aylwin

AU - Kumar, Vinod

AU - Johnson, Melissa D.

AU - Plantinga, Theo S.

AU - Van Diemen, Cleo

AU - Arts, Peer

AU - Verwiel, Eugène T P

AU - Gresnigt, Mark S.

AU - Fransen, Karin

AU - Van Sommeren, Suzanne

AU - Oosting, Marije

AU - Cheng, Shih Chin

AU - Joosten, Leo A B

AU - Hoischen, Alexander

AU - Kullberg, Bart Jan

AU - Scott, William K

AU - Perfect, John R.

AU - Van Der Meer, Jos W M

AU - Wijmenga, Cisca

AU - Netea, Mihai G.

AU - Xavier, Ramnik J.

PY - 2013/10/28

Y1 - 2013/10/28

N2 - Candida albicans is the most common human fungal pathogen causing mucosal and systemic infections. However, human antifungal immunity remains poorly defined. Here by integrating transcriptional analysis and functional genomics, we identified Candida-specific host defence mechanisms in humans. Candida induced significant expression of genes from the type I interferon pathway in human peripheral blood mononuclear cells. This unexpectedly prominent role of type I interferon pathway in anti-Candida host defence was supported by additional evidence. Polymorphisms in type I interferon genes modulated Candida-induced cytokine production and were correlated with susceptibility to systemic candidiasis. In in vitro experiments, type I interferons skewed Candida-induced inflammation from a Th17 response towards a Th1 response. Patients with chronic mucocutaneous candidiasis displayed defective expression of genes in the type I interferon pathway. These findings indicate that the type I interferon pathway is a main signature of Candida-induced inflammation and has a crucial role in anti-Candida host defence in humans.

AB - Candida albicans is the most common human fungal pathogen causing mucosal and systemic infections. However, human antifungal immunity remains poorly defined. Here by integrating transcriptional analysis and functional genomics, we identified Candida-specific host defence mechanisms in humans. Candida induced significant expression of genes from the type I interferon pathway in human peripheral blood mononuclear cells. This unexpectedly prominent role of type I interferon pathway in anti-Candida host defence was supported by additional evidence. Polymorphisms in type I interferon genes modulated Candida-induced cytokine production and were correlated with susceptibility to systemic candidiasis. In in vitro experiments, type I interferons skewed Candida-induced inflammation from a Th17 response towards a Th1 response. Patients with chronic mucocutaneous candidiasis displayed defective expression of genes in the type I interferon pathway. These findings indicate that the type I interferon pathway is a main signature of Candida-induced inflammation and has a crucial role in anti-Candida host defence in humans.

UR - http://www.scopus.com/inward/record.url?scp=84878700149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878700149&partnerID=8YFLogxK

U2 - 10.1038/ncomms2343

DO - 10.1038/ncomms2343

M3 - Article

C2 - 23299892

AN - SCOPUS:84878700149

VL - 4

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 1342

ER -